SMARCB1 and neoplasm: RTK is a highly aggressive tumor occurring in young children, has a dismal outcome, and is characterized by pathological rhabdoid features and molecular biallelic inactivation of the SMARCB1 (hSNF5/INI1) gene [4]–[6].